Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok
ASCO Daily News
Dr. Jedd Wolchok, a pioneer in melanoma research, joins Dr. Monty Pal to break down practice-changing advances in the field, including landmark 10-year CheckMate-067 survival data, safer immunotherapy dosing, and the rise of neoadjuvant treatment.
info_outline
Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities
ASCO Daily News
Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the integration of novel therapies in the advanced setting, and practical strategies for managing toxicities in clinical practice.
info_outline
How Do We Translate ASCO26 Research Into Practice in Latin America?
ASCO Daily News
In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary breakthroughs can be adapted to clinical practice in Latin America. Together, they address real-world implementation challenges including delayed diagnoses, finite resource allocation, and access to precision diagnostics.
info_outline
GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?
ASCO Daily News
Dr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data, immune microenvironment biology, and the need for prospective trials.
info_outline
From Abstract to Action: Translating ASCO26 Research Into Global Practice
ASCO Daily News
How do we translate oncology breakthroughs into practice? In part one of a two-part miniseries, host Dr. Monty Pal and Dr. Atul Batra discuss the clinical realities, opportunities, and challenges of adapting ASCO26 Plenary findings into cancer care worldwide, using India’s health care landscape as a blueprint for resource-limited settings.
info_outline
Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough
ASCO Daily News
Dr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for early multi-cancer detection, AI applications in colorectal cancer screening, and how global advances in breast, esophageal, and small cell lung cancers translate directly to diverse patient populations in the Asia-Pacific region.
info_outline
Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1
ASCO Daily News
Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-stage disease that were presented at the 2026 ASCO Annual Meeting.
info_outline
GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART
ASCO Daily News
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate, bladder, and kidney cancers that were presented at the 2026 ASCO Annual Meeting.
info_outline
Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers
ASCO Daily News
Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting.
info_outline
GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More
ASCO Daily News
Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the 2026 ASCO Annual Meeting.
info_outlineDr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma.